Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Download All
Explore expert-guided education on the use of novel therapies for patients with nonmetastatic hormone-sensitive and castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer with a webcast of a live meeting, downloadable slides, a podcast, and a focused commentary.
Daniel W. Lin, MD
Alicia K. Morgans, MD, MPH
David F. Penson, MD, MPH

On-Demand Webcast

In this interactive on-demand webcast, expert faculty members discuss current clinical guidance and key data on the optimal use of GnRH agonists and antagonists, androgen receptor inhibitors, and other treatments for nonmetastatic or metastatic prostate cancer.

Daniel W. Lin, MD Alicia K. Morgans, MD, MPH David F. Penson, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: October 6, 2021 Expired: October 5, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Astellas
Bayer HealthCare Pharmaceuticals Inc.
Myovant Sciences Ltd.
Pfizer, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue